1. Pink Sheet
  2. >>Regulatory Trackers
  3. >>US FDA Performance Tracker

Pandemic Taking Its Toll On The US FDA’s Non-Pandemic Work, Alkermes CEO Says

 
• By Derrick Gingery

Last year was not the greatest performance by the agency outside of COVID-19, Richard Pops tells BIO conference.

Richard Pops says the advisory committee system is broken and problems are made worse with virtual meetings.

Alkermes plc Chairman and CEO Richard Pops wants the US Food and Drug Administration to remember that its non-coronavirus workload is just as important as its effort to end the pandemic.

Understandably, much of the attention at the agency and outside it has focused on finding therapeutics, diagnostics and vaccines for COVID-19

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from US FDA Performance Tracker

More from Regulatory Trackers